Viracta Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.319; its P/E ratio is -0.65; Viracta Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -13.55M	$ -11.59M	$ -12.12M	$ -10.76M	$ -17.60M
EBITDA	$ -13.55M	$ -12.01M	$ -12.52M	$ -11.15M	$ -17.56M
Net Income Common Stockholders	$ -12.60M	$ -12.48M	$ -12.12M	$ -10.30M	$ -17.74M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 62.95M	$ 72.87M	$ 80.33M	$ 91.04M	$ 77.07M
Total Assets	$ 66.44M	$ 76.86M	$ 85.66M	$ 95.99M	$ 82.20M
Total Debt	$ 25.56M	$ 25.55M	$ 25.54M	$ 25.16M	$ 5.25M
Net Debt	$ -37.39M	$ -47.31M	$ -54.79M	$ -65.89M	$ -71.82M
Total Liabilities	$ 36.43M	$ 36.08M	$ 34.67M	$ 34.89M	$ 14.39M
Stockholders Equity	$ 30.01M	$ 40.78M	$ 51.11M	$ 61.10M	$ 67.81M
Cash Flow	-
Free Cash Flow	$ -10.48M	$ -8.18M	$ -11.34M	$ -7.90M	$ -7.16M
Operating Cash Flow	$ -10.54M	$ -7.99M	$ -11.34M	$ -7.90M	$ -7.16M
Investing Cash Flow	$ 9.10M	$ 3.98M	$ -7.35M	$ -203.00K	$ -52.06M
Financing Cash Flow	-	$ 204.00K	$ 16.00K	$ 21.41M	$ 1.10M

Currency in USD

Viracta Therapeutics Earnings and Revenue History

Income Statement >

Viracta Therapeutics Debt to Assets

Balance Sheet >

Viracta Therapeutics Cash Flow

Cash Flow >

Viracta Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing